Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-27 @ 10:57 PM
Study NCT ID:
NCT03506360
Status:
COMPLETED
Last Update Posted:
2024-01-09
First Post:
2018-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Sponsor:
Mayo Clinic
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent Plasma Cell Myeloma | View |
Keywords: